3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
115
Gliosarcoma
53
Brain Neoplasms
53
Glioma
47
Central Nervous System Neoplasms
30
Astrocytoma
29
Melanoma
26
Oligodendroglioma
14
Neuroblastoma
10
Neoplasm Metastasis
9
Recurrence
7
Ependymoma
7
Sarcoma
6
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Skin Neoplasms
5
Sarcoma, Ewing
5
Lymphoma
5
Breast Neoplasms
5
Spinal Cord Neoplasms
4
Somatostatinoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Medulloblastoma
4
Colorectal Neoplasms
4
Small Cell Lung Carcinoma
3
Lung Neoplasms
3
Gastrinoma
3
Carcinoma, Islet Cell
3
Uveal Melanoma
2
Rhabdomyosarcoma
2
Interventions
Cytarabine
26
Daunorubicin
11
Mitoxantrone
7
Idarubicin
7
Etoposide
7
fludarabine phosphate
6
Filgrastim
6
Busulfan
6
Tacrolimus
5
Peripheral Blood Stem Cell Transplantation
5
Methotrexate
5
Gemtuzumab
5
Clofarabine
5
tipifarnib
4
alvocidib
4
Vorinostat
4
Decitabine
4
Azacitidine
4
sargramostim
3
Whole-Body Irradiation
3
Observation
3
Mycophenolic Acid
3
Granulocyte Colony-Stimulating Factor
3
Bortezomib
3
Biopsy
3
Antilymphocyte Serum
3
entinostat
2
Sirolimus
2
Pravastatin
2
Flow Cytometry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelomonocytic, Acute
×
Temozolomide
×
Clear all
No trials found.